A total of 16,695 shares changed hands on the counter till 02:06PM (IST).

Share price of Colgate-Palmolive falls as Nifty strengthens

Interview with Prabha Narasimhan, MD & CEO, Colgate-Palmolive India

Room for growth if consumers take to proper oral care habits, says Colgate MD & CEO

Normally we would look for something like FMCG but if you see long-term charts of Colgate, I mean they are scary. It seems to have finished a multi-year bull run, Lever going nowhere, Dabur looking heavy. Pharma as a sector you would look at the defensive. IT is a new defensive now, I guess. Pharma …

2 top stock recommendations from Hemen Kapadia

P&G, Unilever, Colgate continued operations after invasion.

For Fear Or Money, Consumer Giants Are Staying In Russia

The stock quoted a 52-week high price of Rs 1695.0 and low of Rs 1387.3.

Colgate-Palmolive shares down 0.74% as Nifty gains

KR Choksey recommended accumulate rating on Colgate Palmolive (India) with a target price of Rs 1638 in its research report dated January 25, 2023.

Accumulate Colgate Palmolive (India); target of Rs 1638: KR Choksey

Colgate q3 results: A lot hinges on its ability to boost volumes amid stiff competition

After a weak Dec quarter, near-term gains unlikely for Colgate-Palmolive

Total operating revenue growth stood at just almost 1% year-on-year (y-o-y) to ₹1,291 crore. The company has not disclosed data on volume performance.

Colgate needs to brush up on growth after another dull quarter

The company performed poorly on all parameters in Q3 FY23 — flat revenue growth, decline in volumes, fall in operating profit, and contraction in operating margin and fall in the profit before tax

‘More focus on personal care portfolio will boost Colgate’s volumes’

Prabhudas Lilladher recommended hold rating on Colgate Palmolive with a target price of Rs 1578 in its research report dated January 24, 2023.

Hold Colgate Palmolive; target of Rs 1578: Prabhudas Lilladher

In today’s edition of Moneycontrol Pro Panorama: Gland Pharma’s poor streak cause for concern, no signs of recovery for Colgate, bailout cannot avert Pakistan’s crisis, Indian economy needs a time-out, and more

Moneycontrol Pro Panorama | Autos on the road to recovery

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Colgate Palmolive (India) Limited is engaged in the personal care and oral care business. The Company offers various personal care products, such as soaps, cosmetics and toilet preparations.